|
Signal Transduction
Citations 151-160 of 1930 total displayed.
|
Past content
(since May 2000):
|
Abnormal hematopoiesis in Gab2 mutant mice
- Yi Zhang, Ernesto Diaz-Flores, Geqiang Li, Zhengqi Wang, Zizhen Kang, Eleonora Haviernikova, Sara Rowe, Cheng-Kui Qu, William Tse, Kevin M. Shannon, and Kevin D. Bunting
Blood 2007; 110: 116-124.
[Abstract]
[Full text]
[PDF]
Tissue factor trafficking in fibroblasts: involvement of protease-activated receptor–mediated cell signaling
- Samir K. Mandal, Usha R. Pendurthi, and L. Vijaya Mohan Rao
Blood 2007; 110: 161-170.
[Abstract]
[Full text]
[PDF]
The May-Hegglin anomaly gene MYH9 is a negative regulator of platelet biogenesis modulated by the Rho-ROCK pathway
- Zhao Chen, Olaia Naveiras, Alessandra Balduini, Akiko Mammoto, Mary Anne Conti, Robert S. Adelstein, Donald Ingber, George Q. Daley, and Ramesh A. Shivdasani
Blood 2007; 110: 171-179.
[Abstract]
[Full text]
[PDF]
Crosstalk between RANKL and Fas signaling in dendritic cells controls immune tolerance
- Takashi Izawa, Naozumi Ishimaru, Keiji Moriyama, Masayuki Kohashi, Rieko Arakaki, and Yoshio Hayashi
Blood 2007; 110: 242-250.
[Abstract]
[Full text]
[PDF]
Dok-3 plays a nonredundant role in negative regulation of B-cell activation
- Chee-Hoe Ng, Shengli Xu, and Kong-Peng Lam
Blood 2007; 110: 259-266.
[Abstract]
[Full text]
[PDF]
NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells
- Claudia P. Miller, Kechen Ban, Melanie E. Dujka, David J. McConkey, Mark Munsell, Michael Palladino, and Joya Chandra
Blood 2007; 110: 267-277.
[Abstract]
[Full text]
[PDF]
Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia
- Steven M. Chan, Andrew P. Weng, Robert Tibshirani, Jon C. Aster, and Paul J. Utz
Blood 2007; 110: 278-286.
[Abstract]
[Full text]
[PDF]
Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN- and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway
- Jizhong Liu, Abdelbasset Hamrouni, Darius Wolowiec, Valérie Coiteux, Kazimierz Kuliczkowski, Dominique Hetuin, Aurore Saudemont, and Bruno Quesnel
Blood 2007; 110: 296-304.
[Abstract]
[Full text]
[PDF]
Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl–mediated drug resistance
- Jennifer S. Carew, Steffan T. Nawrocki, Charissa N. Kahue, Hui Zhang, Chunying Yang, Linda Chung, Janet A. Houghton, Peng Huang, Francis J. Giles, and John L. Cleveland
Blood 2007; 110: 313-322.
[Abstract]
[Full text]
[PDF]
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation
- Luciana Teofili, Maurizio Martini, Tonia Cenci, Giovanna Petrucci, Lorenza Torti, Sergio Storti, Francesco Guidi, Giuseppe Leone, and Luigi Maria Larocca
Blood 2007; 110: 354-359.
[Abstract]
[Full text]
[PDF]
|
|
